| Title |
Navigant Biotechnologies |
| Description |
Navigant Biotechnologies is developing techniques to improve the safety of the blood supply by reducing the pathogens found in donated blood. The unique Mirasol Pathogen Reduction Technology (PRT), from Navigant Biotechnologies applies light and riboflavin to alter the nucleic acids and proteins of pathogens, rendering them inactive. This is the first single technology that has been shown to inactivate pathogens in all three major blood components: red blood cells, platelets and plasma. |
| Comments * |
|
